Evommune, Inc.

Evommune is a biotechnology company developing drugs to treat chronic inflammatory diseases. The company is still in clinical testing stages, meaning its treatments have not yet been approved by regulators. Its experimental drugs are designed to treat conditions like chronic hives, eczema, and ulcerative colitis, which are long-term inflammatory conditions affecting the skin and digestive system. The company was founded in 2020 and is based in Palo Alto, California.